Diplomat Pharmacy Inc DPLO:NYSE

Last Price$3.94NYSE Previous Close - Last Trade as of 6:30PM ET 12/12/19
NYSE 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.92 (103)
Ask (Size)$3.95 (50)
Day Low / HighN/A - N/A
Volume2.9 M

View Hospital/Nursing Management IndustryPeer Comparison as of 12/12/2019


Diplomat Pharmacy Inc ( NYSE )

Price: $3.94
Change: +0.01 (0.25%)
Volume: 2.9 M
6:30PM ET 12/12/2019

Genesis Healthcare Inc ( NYSE )

Price: $1.62
Change: -0.10 (5.81%)
Volume: 1.00
6:30PM ET 12/12/2019

Viemed Healthcare Inc ( NASDAQ )

Price: $6.29
Change: -0.16 (2.41%)
Volume: 4.9 K
3:59PM ET 12/12/2019

Joint Corp ( NASDAQ )

Price: $17.19
Change: -0.31 (1.80%)
Volume: 134.7 K
3:59PM ET 12/12/2019

Community Health Systems Inc ( NYSE )

Price: $3.51
Change: 0.00 (0.00%)
Volume: 1.2 M
6:30PM ET 12/12/2019

Read more news Recent News

UnitedHealth Pharmacy-Care Services Unit to Acquire Diplomat Pharmacy for $304 Million in Cash
1:41PM ET 12/09/2019 MT Newswires

UnitedHealth Group's (UNH) pharmacy-care services unit will acquire Diplomat Pharmacy (DPLO), the companies said on Monday, in a deal valued at about $304...

UnitedHealth Group's Optum to Acquire Diplomat Pharmacy for $303 Million
1:35PM ET 12/09/2019 MT Newswires

OptumRx, the pharmacy care services business of UnitedHealth Group's (UNH) Optum said Monday that it agreed to acquire specialty pharmacy and infusion...

Analyst Actions: William Blair Upgrades Diplomat Pharmacy to Market Perform From Underperform
1:20PM ET 12/09/2019 MT Newswires

Diplomat Pharmacy (DPLO) has an average hold rating among analysts with a $9 average price target. Price: 3.94, Change: -1.88, Percent Change: -32.27 ...

Analyst Actions: Credit Suisse Trims Price Target for Neutral-Rated Diplomat Pharmacy to $4 From $5
1:19PM ET 12/09/2019 MT Newswires

Diplomat Pharmacy (DPLO) has an average hold rating among analysts with a $9 average price target. Price: 3.94, Change: -1.88, Percent Change: -32.27 ...

Company Profile

Business DescriptionDiplomat Pharmacy, Inc. engages in the provision of specialty pharmacy and infusion services. It operates through the Specialty and Pharmacy Benefit Management segments. The Specialty segment offers a range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost specialty drugs, and a wide range of applications. The Pharmacy Benefit Management segment provides services designed to help the customers reduce the cost and manage the complexity of their prescription drug programs. The company was founded by Dale Hagerman and Philip Hagerman in 1975 and is headquartered in Flint, MI. View company web site for more details
Address4100 South Saginaw Street
Flint, Michigan 48507-2683
Number of Employees2,335
Recent SEC Filing12/10/2019SC14D9C
Chairman & Chief Executive OfficerBrian T. Griffin
Chief Operating OfficerDave Loschinskey
Chief Financial Officer & TreasurerDan Davison
Senior Vice President & ControllerGeorge Manor

Company Highlights

Price Open$3.94
Previous Close$3.94
52 Week Range$2.43 - 15.32
Market Capitalization$299.3 M
Shares Outstanding76.0 M
SectorHealth Services
IndustryHospital/Nursing Management
Next Earnings Announcement03/20/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.00
Beta vs. S&P 500N/A
Revenue$5.5 B
Net Profit Margin-12.47%
Return on Equity-191.83%

Analyst Ratings as of 12/09/2019

Consensus RecommendationConsensus Icon
Powered by Factset